Description
Recombinant monoclonal antibody to CA19-9. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 4A6. This is a reformatted human IgG1 Fc SilentЩ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
Target
CA19-9
Target Alias Names
CA 19-9, sialyl-Lewis, Carbohydrate antigen 19-9, tumor marker
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression